Evidence map›Paper›PMID 35138162›Full record

ArticleMicrobiology spectrum2022

Gut Microbiome-Targeted Modulations Regulate Metabolic Profiles and Alleviate Altitude-Related Cardiac Hypertrophy in Rats.

Yichen Hu, Zhiyuan Pan, Zongyu Huang, Yan Li, Ni Han, Xiaomei Zhuang, Hui Peng, Quansheng Gao, Qing Wang, B J Yang Lee and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Microbial-Derived Exerkines Prevent Skeletal Muscle Atrophy.bioRxiv : the preprint server for biology · 2024
    Article
  17. Nutrients · 2024
    Article
  18. Article
  19. Review
  20. Frontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Yichen HuState Key Laboratory of Food Science and Technology, Nanchang Universitygrid.260463.5, Nanchang, People's Republic of China.
Zhiyuan PanState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.
Zongyu HuangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.
Yan LiState Key Laboratory of Food Science and Technology, Nanchang Universitygrid.260463.5, Nanchang, People's Republic of China.
Ni HanState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.
Xiaomei ZhuangInstitute of Pharmacology and Toxicology, Beijing, People's Republic of China.
Hui PengTianjin Institute of Environmental and Operational Medicine, Tianjin, People's Republic of China.
Quansheng GaoTianjin Institute of Environmental and Operational Medicine, Tianjin, People's Republic of China.
Qing WangBeijing Hi-LongCare Medicine & Technology Co., Ltd., Beijing, People's Republic of China.
B J Yang LeeBeijing Future Science & Technology Development Co., Ltd., Beijing, People's Republic of China.
Heping Zhang *Key Laboratory of Dairy Biotechnology and Engineering, Education Ministry of People's Republic of China, Department of Food Science and Engineering, Inner Mongolia Agricultural Universitygrid.411638.9, Hohhot, People's Republic of China.
Ruifu Yang *State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.
Yujing BiState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.ORCID 0000-0002-8309-2259
Zhenjiang Zech XuState Key Laboratory of Food Science and Technology, Nanchang Universitygrid.260463.5, Nanchang, People's Republic of China.ORCID 0000-0003-1080-024X
Institute of Microbiology · CNNanchang University · CNInner Mongolia Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that humans physiologically or pathologically respond to high altitude, with these responses accompanied by alterations in the gut microbiome. To investigate whether gut microbiota modulation can alleviate high-altitude-related diseases, we administered probiotics, prebiotics, and synbiotics in rat model with altitude-related cardiac impairment after hypobaric hypoxia challenge and observed that all three treatments alleviated cardiac hypertrophy as measured by heart weight-to-body weight ratio and gene expression levels of biomarkers in heart tissue. The disruption of gut microbiota induced by hypobaric hypoxia was also ameliorated, especially for microbes of

Indexed as

Gastrointestinal MicrobiomeAltitudeAmino AcidsAnimalsBile Acids and SaltsBiomarkersCardiomegalyFatty Acids, VolatileHumansMaleMetabolomeNeurotransmitter AgentsRatsRats, WistarAmino AcidsBile Acids and SaltsBiomarkersFatty Acids, VolatileNeurotransmitter Agents16S rRNAcardiac hypertrophyhypobaric hypoxiametabolomemicrobiota

Identifiers

PMID35138162
PMCPMC8826942
OpenAlexW4210939529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.